Contribution of New Generation Oxford Nanopore-type High-throughput Sequencing in the Diagnostic Strategy of Neurogenetic Diseases.
Clinical trial NCT04621422 · UNKNOWN
Trial details
- NCT number
- NCT04621422
- Sponsor
- University Hospital, Bordeaux
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.